Company intelligence / Profile preview

Lexington Holding Assets

Road Town, British Virgin Islands

Ownership: Private
Development stage: Other

Overview

Lexington Holding Assets is a holding and investment vehicle rather than an operating life sciences, biotech, pharma, or healthcare company. Publicly available information links it to corporate and investment activities, including participation in the 2023 bid consortium that sought to acquire IRRAS AB through IR Holding Bidco. There is no clear evidence that Lexington Holding Assets develops therapeutics, diagnostics, medical devices, or healthcare services under its own name. Based on available records, it appears to function as a legal entity used for asset holding and transaction structuring.

Industry: Investors

Partnerships

IR Holding Bidco consortium for the IRRAS AB acquisition bid

Beyond the preview

Go deeper on Lexington Holding Assets.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lexington Holding Assets.

Explore the full profile